RAMM Pharma (XCNQ:RAMM) Inventories, Finished Goods: C$0.54 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RAMM Pharma Inventories, Finished Goods?

RAMM Pharma XCNQ:RAMM Inventories, Finished Goods is C$0.54 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's quarterly finished goods declined from Jul. 2025 (C$1.03 Mil) to Oct. 2025 (C$0.78 Mil) and declined from Oct. 2025 (C$0.78 Mil) to Jan. 2026 (C$0.54 Mil).

RAMM Pharma's annual finished goods declined from Oct. 2023 (C$1.27 Mil) to Oct. 2024 (C$1.16 Mil) and declined from Oct. 2024 (C$1.16 Mil) to Oct. 2025 (C$0.78 Mil).

RAMM Pharma Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Inventories, Finished Goods Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Inventories, Finished Goods
Get a 7-Day Free Trial 1.04 1.71 1.27 1.16 0.78

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.33 1.22 1.03 0.78 0.54

RAMM Pharma Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of C$0.54 Mil mean?
RAMM Pharma (XCNQ:RAMM) has a Inventories, Finished Goods of C$0.54 Mil as of Jan. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Inventories, Finished Goods too high?
RAMM Pharma's current Inventories, Finished Goods is C$0.54 Mil.
How does RAMM Pharma's Inventories, Finished Goods compare to ZTS and UTHR?
RAMM Pharma's Inventories, Finished Goods of C$0.54 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Inventories, Finished Goods is C$0.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Inventories, Finished Goods is C$0.54 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Inventories, Finished Goods is C$0.54 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.